DrugRisk: Pradaxa Side Effect Reports Top 22,000 As Lawsuits Grow

Share Article

The Drug Risk Resource Center is the Web’s largest source for information on prescription drug research, side effects and legal news. Visit http://www.DrugRisk.com

pradaxa lawsuit
Anyone affected by internal bleeding after taking Pradaxa is urged to visit the DrugRisk Resource Center or speak with a lawyer about their legal options as soon as possible.

The DrugRisk Resource Center is alerting patients taking the blood thinner Pradaxa that reports of side effects to the FDA have topped 20,000. Also, the maker of the drug faces growing litigation over alleged bleeding injuries and deaths.

According to the Adverse Events Report on December 10th tracking FDA AERS reports through June 30, 2012, the agency has received 22,952 reports of complications among patients taking Pradaxa.*

Most common among these were 6497 gastrointestinal side effects, 4910 gastrointestinal hemorrhages (bleeding) and 2941 central nervous system or cranial hemorrhaging problems. There were also 842 deaths attributed to the drug.

The news comes as the latest report from the Judicial Panel on MultiDistrict Litigation shows the number of Pradaxa lawsuits over internal bleeding has risen 50% since September.**

Anyone affected by internal bleeding after taking Pradaxa is urged to visit the DrugRisk Resource Center or speak with a lawyer about their legal options as soon as possible.

Health experts continue to disagree about the safety of Pradaxa and its relation to dangerous or fatal internal bleeding. Last month, the FDA updated its warnings to say that, for now, testing shows Pradaxa carries the same risks as warfarin and Coumadin.*** However, the New York Times reported doctors’ concerns the same day that Pradaxa led all other medications for adverse reports and currently has no antidote for internal bleeding caused by Pradaxa.****

Due to the growing number of Pradaxa lawsuits, cases have been moved to a special federal court in Illinois. The formal case is known as MDL No. 2385, IN RE: Pradaxa Product Liability Litigation, Southern District of Illinois.

Anyone affected by internal bleeding after Pradaxa use is urged to speak with a lawyer about their legal options as soon as possible. Due to the specialized nature of federal drug injury cases, the Drug Risk Resource Center only recommends lawyers who are already handling Pradaxa lawsuits.

For more information on the research, side effects and litigation news related to Pradaxa and other drugs, or to speak with a lawyer, visit http://www.DrugRisk.com.

*drugcite.com/?q=pradaxa
**jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets-By-District-November-2012.pdf
***fda.gov/Drugs/DrugSafety/ucm326580.htm
****nytimes.com/2012/11/03/business/a-rising-anti-stroke-drug-is-tied-to-risk-of-bleeding-deaths.html

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Patient Advocate
DrugRisk
888-415-1859
Email >
Visit website